Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...

offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or "TMS”) and Spravato® (esketamine nasal spray) for the treatment of major depressive disorder ("MDD”) and other mental ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient clinic ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...

President Donald Trump signed an executive order on Tuesday to ban federal funding and assistance for gender-affirming care for people under the age of 19. The order refers to the use of puberty ...